Open Access Policy

Open Access Policy

Scientific knowledge and research findings must be available to the global community, and Medvix is committed to this. Our mission is to promote unrestricted access to high-quality scholarly content across diverse disciplines.

Key principles of our Open Access Policy

  1. Immediate access—As soon as an article is published, it is immediately and available online on the Medvix website. Readers worldwide can access, read, download, and share without subscription barriers.
  2. Knowledge sharing globally—Medvix encourages the widespread dissemination of scientific and medical knowledge as part of its open-access policy. It also fosters innovation and collaboration among researchers, practitioners, and academics worldwide.
  3. Creative Commons Licensing – Medvix published articles under the Creative Commons Attribution 4.0 International (CC-BY-4.0) license. This allows readers to –
    1. Share – Copy and redistribute the material in any medium and format.
    2. Adapt – Reuse, remix, transform, and build upon the material for any purpose, including commercially.
    3. Conditions
      1. Proper attribution must be given to the original author(s).
      2. Changes made to the original work in any form must be indicated.
      3. No legal or technical restrictions must be made.
  4. Author rights—The Author retains all rights to the original work they contribute and grants Medvix the right to publish and distribute it under the CC-BY-4.0 license. This ensures that the authors maintain control over their intellectual property while contributing to the international community's open knowledge.
  5. Commitment to ethical publishing—At Medvix, we are committed to and adhere to the highest standards of academic integrity and ethical publishing, ensuring that all open-access content is peer-reviewed and of the highest standards.

Medvix strives to democratize access to research with our Open Access Policy and encourages global academic collaboration while driving progress in science, medicine, and beyond.